Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: A national claims database analysis

Current Medical Research and Opinion

Volumn 28, Issue 4, 2012, Pages 657-663

  Sun, Peter ^a   Kohrman, Michael ^b   Liu, Jamae ^c   Guo, Amy ^c   Rogerio, Jaqueline ^c   Krueger, Darcy ^d  

^a Kailo Research Group   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Clinical effectiveness; Repeated surgery; SEGA recurrence; Subependymal giant cell astrocytoma; Surgical complications; Tuberous sclerosis complex

Indexed keywords

ARTICLE; ASTROCYTOMA; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PREVALENCE; REOPERATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE CLAIM REVIEW; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TUBEROUS SCLEROSIS;

EID: 84859730974     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.658907     Document Type: Article

References (42)

1. Chan JA, Zhang H, Roberts PS, et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 2004;63:1236-42 (Pubitemid 39603395)
2. Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 4 2010;363: 1801-11
3. Kwiatkowski D, Whittenmore V, Thiele E, eds. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. Wiley-Blackwell, 2010
4. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 28 2006;355:1345-56
5. Wiestler OD, Lopes BS, Green AJ, et al. Tuberous sclerosis complex and subependymal giant cell astrocytoma. Kleihues P, Cavenee WK World Health Organization classification of tumours. Pathology and geneticstumours of the nervous system. Lyon: IARC Press, 2000
6. Gomez MR. History of the tuberous sclerosis complex. Brain Dev 1995;17(Suppl):55-7 (Pubitemid 26078843)
7. Gomez MR, Sampson J, Whittenmore V, eds. Tuberous Sclerosis Complex: Developmental Perspectives in Psychiatry, 3rd edn. New York: Oxford University Press, 1988
8. Asato MR, Hardan AY. Neuropsychiatric problems in tuberous sclerosis complex. J Child Neurol 2004;19:241-9 (Pubitemid 38660205)
9. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125-7
10. Shepherd CW, Beard CM, Gomez MR, et al. Tuberous sclerosis complex in Olmsted County, Minnesota, 1950-1989. Arch Neurol 1991;48: 400-1
11. Hallett L, Foster T, Liu Z, et al. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 2011;27:1571-83
12. NINDS. Tuberous Sclerosis Fact Sheet. 2010; http://www.ninds.nih.gov/ disorders/tuberous-sclerosis/detail-tuberous-sclerosis.htm#one. Accessed June 22, 2010
13. Roth J, Olasunkanmi A, MacAllister WS, et al. Quality of life following epilepsy surgery for children with tuberous sclerosis complex. Epilepsy Behav 2011;20:561-5
14. Zaroff CM, Devinsky O, Miles D, et al. Cognitive and behavioral correlates of tuberous sclerosis complex. J Child Neurol 2004;19:847-52 (Pubitemid 40090101)
15. Berhouma M. Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective. World J Pediatr 2010;6:103-10
16. de Ribaupierre S, Dorfmuller G, Bulteau C, et al. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 2007;60:83-9; discussion 89-90 (Pubitemid 46102922)
17. Di Rocco C, Iannelli A, Marchese E. On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis. Pediatr Neurosurg 1995;23:115-21
18. Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology2004;63:1457-61 (Pubitemid 39426281)
19. Sinson G, Sutton LN, Yachnis AT, et al. Subependymal giant cell astrocytomas in children. Pediatr Neurosurg 1994;20:233-9 (Pubitemid 24169120)
20. Hirose T, Scheithauer BW, Lopes MB, et al. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol 1995;90:387-99
21. O'Callaghan FJ, Martyn CN, Renowden S, et al. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 2008;93:751-4
22. Ozek MM, Ozek E, Pamir MN, et al. Subependymal giant cell astrocytomas in tuberous sclerosis. Turk J Pediatr 1993;35:145-50
23. Fujiwara S, Takaki T, Hikita T, et al. Subependymal giant-cell astrocytoma associated with tuberous sclerosis. Do subependymal nodules grow? Childs Nerv Syst 1989;5:43-4 (Pubitemid 19055989)
24. Adriaensen ME, Schaefer-Prokop CM, Stijnen T, et al. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 2009;16:691-6
25. Connolly MB, Hendson G, Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv Syst 2006;22:896-908 (Pubitemid 44103018)
26. de Vries P, Humphrey A, McCartney D, et al. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis. Eur Child Adolesc Psychiatry 2005;14:183-90
27. Roach ES, DiMario FJ, Kandt RS, et al. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999;14:401-7 (Pubitemid 29321101)
28. Ahmad Z, Rauf F, Azad NS, et al. Subependymal giant cell astrocytoma. J Pak Med Assoc 2006;56:463-5 (Pubitemid 44904906)
29. Cai R, Di X. Combined intra-and extra-endoscopic techniques for aggressive resection of subependymal giant cell astrocytomas. World Neurosurg 2010;73:713-18
30. Holanda FJ, Holanda GM. Tuberous sclerosis-neurosurgical indications in intraventricular tumors. Neurosurg Rev 1980;3:139-50
31. Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 2000;57:662-5 (Pubitemid 30252800)
32. Johnson SR. The ERS guidelines for LAM: Trying a rationale approach to a rare disease. Respir Med 2010;104(Suppl 1):S33-41
33. Levine NB, Collins J, Franz DN, et al. Gradual formation of an operative corridor by balloon dilation for resection of subependymal giant cell astrocytomas in children with tuberous sclerosis: specialized minimal access technique of balloon dilation. Minim Invasive Neurosurg 2006;49:317-20 (Pubitemid 46032028)
34. Bongiorni L, Arroyo HA, Lubienicki F. [Subependymal nodules-sudependymal giant cell astrocytoma complex in children with tuberous sclerosis]. Medicina (B Aires) 2009;69(1 Pt 1):8-14
35. Ekici MA, Kumandas S, Per H, et al. Surgical timing of the subependymal giant cell astrocytoma (SEGA) with the patients of tuberous sclerosis complex. Turk Neurosurg 2011;21:315-24
36. Kim SK, Wang KC, Cho BK, et al. Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. J Neurooncol 2001;52:217-25
37. Park KJ, Kano H, Kondziolka D, et al. Gamma knife surgery for subependymal giant cell astrocytomas. Clinical article. J Neurosurg 2011;114:808-13
38. Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, et al. [Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients]. Neurologia 2010;25:314-21
39. Reuters T. MarketScan Research Databases. 2011; http://thomsonreuters. com/content/healthcare/pdf/products/MarketScan-SELLSHEEThealthp1.pdf. Accessed August 20, 2011, 2001
40. IMS. PharMetrics Integrated Database. 2011; http://www.imshealth.se/ portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/? vgnextoid6d7660b6f5aa0210VgnVCM100000ed152ca2RCRD&vgnex tfmtdefault. Accessed August 20, 2011, 2011
41. Phi JH, Park SH, Chae JH, et al. Congenital subependymal giant cell astrocytoma: clinical considerations and expression of radial glial cell markers in giant cells. Childs Nerv Syst 2008;24:1499-503
42. Sharma M, Ralte A, Arora R, et al. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Pathology 2004;36:139-44 (Pubitemid 38507874)